🇺🇸 FDA

Intelligence · Clinical Pipeline

Infectious disease · Approved programs

Infectious disease programs at Approved programs — ClinicalTrials.gov pipeline intelligence.

Programs
151

Quick answer

Infectious disease Approved programs programs: NovaPharmaNews indexes 151 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Page 2 of 4

  1. Experimental Group

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    4 trials

  2. Experimental vaccine 1

    Sinovac Research and Development Co.,

    COVID-19

    approved mab on hold

    1 trial

  3. FOSFOMYCIN

    The George Institute

    Uncomplicated urinary tract infection (uUTI)

    approved small molecule active

    1 trial

  4. FTC-TDF PrEP

    United Therapeutics Europe Ltd

    HIV Infection

    approved small molecule completed

    1 trial

  5. Fluconazol Accord 50 mg capsules, hard, Diflucan I.V. 2 mg/ml, oplossing voor infusie, Diflucan 100 mg, capsule, hard, Diflucan 10 mg/ml, poeder voor orale suspensie

    Disc Medicine

    Fungal infection

    approved small molecule active

    1 trial

  6. Fludesoxiglucosa (18F)-Curium 185 MBq/ml, solución inyectable

    The George Institute

    Cardiovascular device infections

    approved small molecule active

    1 trial

  7. Ganciclovir

    Hoffmann-La Roche

    Cytomegalovirus Infections

    approved small molecule completed

    1 trial

  8. Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    The George Institute

    Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV

    approved small molecule active

    1 trial

  9. Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Pierre Fabre Australia Pty Ltd

    giving a commercially available vaccine to women with HIV under treatment, women living with HIV traeted by antiretroviral

    approved small molecule active

    1 trial

  10. Harvoni (Fixed dose combination ledipasvir/sofosbuvir)

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    approved small molecule completed

    1 trial

  11. Healive (hepatitis A vacine(human diploid cell), inactivated)

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab active

    1 trial

  12. Healive+Healive

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  13. Healive® Lot 1

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  14. Hepatitis B vaccine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Hepatitis B Vaccination, HIV

    approved mab active

    1 trial

  15. High-dosage SARS-CoV-2 vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial

  16. High-dosage of COVID-19 vaccine (Vero cell), Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  17. Honghe Fujie lotion

    The First People's Hospital of Lianyungang

    Bacterial Vaginitis

    approved small molecule active

    1 trial

  18. IXCHIQ

    Ars Pharmaceuticals Irl Limited

    Chikungunya Virus Infection

    approved mab active

    1 trial

  19. Imipenem

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial

  20. Inactivated COVID-19 vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    approved mab active

    1 trial

  21. Inactivated HAV vaccine

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  22. Inactivated Hepatitis A vaccine (HAV)

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  23. Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial

  24. Inactivated SARS-CoV-2 Vaccine (Vero cell）

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  25. Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    SARS-CoV-2 Infection

    approved mab active

    1 trial

  26. Investigational 23-valent PPV

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    2 trials

  27. Isoniazid Aminosalicylate Tablets

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Reinfection Pulmonary Tuberculosis

    approved small molecule active

    1 trial

  28. Keverprazan

    The First People's Hospital of Lianyungang

    H. Pylori Infection

    approved small molecule active

    1 trial

  29. LINEZOLID, LINEZOLID

    The George Institute

    Sepsis

    approved small molecule active

    1 trial

  30. LIVTENCITY 200 mg film-coated tablets.

    The George Institute

    Transplant patients with high recurrent Epstein-Barr infection

    approved small molecule active

    1 trial

  31. Levofloxacin

    Hospital Authority, Hong Kong

    Urinary Tract Infection

    approved small molecule active

    1 trial

  32. Longidaza

    The First People's Hospital of Lianyungang

    Bacterial Vaginosis

    approved small molecule active

    1 trial

  33. Mecobalamin

    Sichuan Provincial People's Hospital

    Sepsis

    approved small molecule active

    1 trial

  34. Methylprednisolone and Mycophenolate mofetil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hepatitis

    approved small molecule active

    1 trial

  35. Metronidazole

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  36. Metronidazole vaginal suppositories

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bacterial Vaginosis

    approved small molecule active

    1 trial

  37. Nafamostat mesilate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial

  38. Norfloxacino Sandoz 400 mg comprimidos EFG

    The George Institute

    Hospitalized patients with decompensated cirrhosis, diagnosed with bacterial infection evolution lasting for 48 hours or less.

    approved small molecule active

    1 trial

  39. Oral Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    HIV-1-infection

    approved small molecule completed

    1 trial

  40. PEG-IFN alfa-2a

    Hoffmann-La Roche

    Hepatitis C, Chronic

    approved small molecule completed

    1 trial

  41. PLACEBO, ISMIGEN tabletki podjezykowe

    Lacuna Pharma Pty Ltd

    Respiratory Tract Infections

    approved small molecule active

    1 trial

  42. PYTEST® 14C-Urea Breath Test

    Phathom Pharmaceuticals

    H Pylori Infection

    approved small molecule active

    1 trial

  43. PYTEST® 14C-Urea Capsule Breath Test (at Home)

    Phathom Pharmaceuticals

    H. Pylori Infection

    approved small molecule active

    1 trial

  44. Peginterferon alfa

    Third Affiliated Hospital, Sun Yat-Sen University

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  45. Peginterferon alfa-2a

    Vera Therapeutics

    Hepatitis B, Chronic

    approved small molecule active

    1 trial

  46. Pfizer-BioNTech mRNA COVID-19 vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    COVID -19

    approved small molecule active

    1 trial

  47. Pharmacotherapy for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved small molecule completed

    1 trial

  48. Pidotimod

    Almirall, S.A.

    Recurrent Respiratory Tract Infections

    approved small molecule completed

    1 trial

Frequently asked questions

How many infectious disease Approved programs programs exist?

151 programs match both the therapeutic area and stage filters in our published index.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.